Attendes
Countries
Invited Speakers
Abstract Presenters
ATTD-ASIA 2026:
Where the World Converges
Join us in Kyoto for the highly anticipated 3rd Asian Conference on Innovative Therapies for Diabetes Management (ATTD-ASIA 2026), where cutting-edge diabetes research and innovative technologies take center stage on 9-11 December 2026. This conference is an exclusive platform designed for the Asian diabetes community, showcasing the latest advancements in therapies and management techniques tailored to the unique needs of the region.
ATTD-ASIA is more than just an event; it’s a conversation by Asia, for Asia. We are fostering a collaborative dialogue between the East and West, highlighting how advancements in diabetes care can be integrated into the Asian market. Expect thought-provoking discussions, groundbreaking research, and new opportunities to drive forward diabetes management practices.
Don’t miss your chance to be part of this transformative event!
Who Attends ATTD-ASIA
CLINICIAN
CLINICIAN
As a clinician, you are a healthcare professional who specializes in diagnosing, managing, and treating diabetes and its related complications
DIABETES CARE PROVIDERS
DIABETES CARE PROVIDERS
As a diabetes care provider, you help diagnose, manage, and treat diabetes through personalized care. You educate patients on blood sugar control, lifestyle modifications, and medication use while addressing complications. Your role spans clinical treatment, technology integration, and collaborative care with a multidisciplinary team.
RESEARCHERS
RESEARCHERS
As a researcher you investigate the causes, treatments, and prevention of diabetes through clinical and laboratory studies. You analyze data, test new therapies, and explore advancements in technology, genetics, and lifestyle interventions. Your work contributes to developing innovative treatments, improving patient outcomes, and shaping future guidelines.
INDUSTRY LEADERS
INDUSTRY LEADERS
As an industry leader you are an influential professional driving innovation, research, and policy advancements in diabetes care. You lead pharmaceutical, medical device, and healthcare organizations, shaping the development of new treatments, technologies, and best practices.
INVESTORS
INVESTORS
As an investor you fund innovative startups, biotech firms, and medical technology companies developing new treatments and solutions for diabetes care. You analyze market trends, emerging therapies, and digital health advancements to support projects with high growth potential.
Useful information about Kyoto
Experience the future of diabetes management in Japan! Learn tips and tricks to get around Kyoto.
Subscribe to our newsletter
Always stay up-to-date on the latest development, important deadlines and news about ATTD-ASIA 2026
#ATTDASIA26
